Back to Search Start Over

Double-blind, placebo-controlled, multicenter randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, HER2-negative, operable breast cancer

Authors :
Guarneri, Valentina
Generali, Dg
Frassoldati, A
Artioli, F
Boni, C
Cavanna, L
Tagliafico, E
Maiorana, A
Bottini, A
Cagossi, K
Bisagni, G
Piacentini, F
Ficarra, G
Bettelli, S
Roncaglia, E
Nuzzo, S
Swaby, R
Ellis, C
Holford, C
Conte, Pierfranco
Publication Year :
2014
Publisher :
American Society of Clinical Oncology , 330 JOHN CARLYLE ST, STE 300, ALEXANDRIA, USA, VA, 22314, 2014.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3657..a58fa68251bdbcf234013ee8324f1525